Skip to main content
Sai Life Sciences Limited logo

Sai Life Sciences Limited — Investor Relations & Filings

Ticker · SAILIFE ISIN · INE570L01029 LEI · 335800JBS3NY25NIBC93 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 235 across all filing types
Latest filing 2025-02-19 Regulatory Filings
Country IN India
Listing BSE.NS SAILIFE

About Sai Life Sciences Limited

https://www.sailife.com

Sai Life Sciences Limited is a full-service Contract Research, Development, and Manufacturing Organization (CRO-CDMO) that partners with global pharmaceutical and biotechnology innovators to accelerate the discovery, development, and commercialization of complex small molecules. The company provides an integrated platform of services spanning discovery chemistry and biology, DMPK, toxicology, process development, analytical R&D, and commercial-scale manufacturing. With a focus on operational excellence and regulatory compliance, it operates state-of-the-art R&D and manufacturing facilities. Its value proposition centers on the Sai Nxt initiative, which emphasizes investments in advanced technologies, expanded capacity, and a global delivery model designed to reduce time-to-market for novel therapeutics.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (2185 characters) informing stock exchanges about a scheduled meeting with analysts/investors. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is an intimation or announcement of a meeting schedule rather than a detailed investor presentation or financial report. It does not contain financial data, analysis, or detailed presentation materials. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2025-02-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (2158 characters) informing stock exchanges about a scheduled meeting with an analyst/investor. It explicitly states that no new presentation will be made and no unpublished price sensitive information will be discussed. The document is an announcement of a meeting schedule rather than a financial report or detailed presentation. It does not contain financial data, management discussion, or regulatory certifications. Therefore, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement category for miscellaneous filings that do not fit other specific categories.
2025-02-19 English
Updates
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Un-audited Financial Results for the quarter and nine months ended 31 December 2024' and includes detailed financial statements for the quarter and nine months ended December 31, 2024. It references compliance with Indian Accounting Standard 34 (Ind AS 34) on Interim Financial Reporting and SEBI Listing Regulations, which govern quarterly and interim financial disclosures. The document contains comprehensive financial data, including income, expenses, profit, tax, earnings per share, and notes explaining the results. It also includes an Independent Auditor's Review Report specifically on the interim financial results, confirming it is a review of interim financial information rather than a full annual audit. The presence of quarterly and nine-month financial data, auditor's review, and reference to Ind AS 34 clearly indicate this is an Interim / Quarterly Report. The document length (15,000 characters) and detailed financial content confirm it is the report itself, not merely an announcement or certification. Therefore, the appropriate classification is 'IR' (Interim / Quarterly Report). 9M 2025
2025-02-15 English
Options to purchase securities
Share Issue/Capital Change Classification · 100% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the allotment of equity shares under the Employees Stock Option Plan (ESOP) 2008. It references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, and provides detailed disclosures as per SEBI regulations and circulars. The content includes specifics about the number of shares allotted, exercise price, and other regulatory details related to share allotment under ESOP. This is a clear update on a capital change event involving issuance of shares upon exercise of stock options. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about share allotment and capital structure change. Therefore, the appropriate classification is "Share Issue/Capital Change" (SHA). The document length and detail confirm it is not a mere announcement of a report but a substantive regulatory filing about share allotment.
2025-02-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled meeting with an analyst/investor. It explicitly states that no new presentation will be made and that the company does not intend to discuss unpublished price sensitive information. The document is an intimation or announcement of an upcoming event rather than a detailed report or transcript. It is only 2158 characters long, which is quite short and does not contain any financial data or detailed analysis. Therefore, it is not an investor presentation (IP), call transcript (CT), or any financial report. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement related to compliance with SEBI regulations and disclosure requirements.
2025-02-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) about the schedule of a meeting with analysts/investors. It references SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which govern disclosure of material events. The content is about informing the exchanges and public about an upcoming investor meeting, explicitly stating no new presentation will be made and no unpublished price sensitive information will be discussed. The document is short (3254 characters) and serves as an announcement of an event rather than a report or detailed financial disclosure. It does not contain financial data, earnings, or management discussion. This fits the category of a Regulatory Filing (RNS), which is a general regulatory announcement that does not fit other specific categories.
2025-02-12 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.